Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.

Publisher: Kluwer Academic Country of Publication: United States NLM ID: 8803967 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0920-8569 (Print) Linking ISSN: 09208569 NLM ISO Abbreviation: Virus Genes Subsets: MEDLINE

Publication: Boston Ma : Kluwer Academic
Original Publication: Boston, USA : M. Nijhoff, 1987-

Genome, Viral* ; Mutation* ; Repetitive Sequences, Nucleic Acid*; Herpesvirus 2, Gallid/*genetics ; Marek Disease Vaccines/*genetics; Animals ; Base Sequence ; Cells, Cultured ; Codon, Initiator/genetics ; DNA, Viral/genetics ; Ducks ; Herpesvirus 2, Gallid/immunology ; Marek Disease/prevention & control ; Marek Disease/virology ; Molecular Sequence Data ; Open Reading Frames ; Polymorphism, Single Nucleotide ; Sequence Alignment ; Serial Passage ; Vaccines, Attenuated/genetics ; Viral Proteins/genetics

Marek's disease (MD) is the leading cause of losses in chicken production in the world. Over the past 40 years significant progress has been made in the control of MD through the use of vaccines which reduce or delay tumor formation in vaccinated flocks. However, these vaccines fail to induce an immune response that protects against infection and virus shedding. Little is known about the genetic changes that lead to attenuation and are necessary for the generation of vaccine strains. Previous research has demonstrated that serial passage of virulent strains in cell culture results in the generation of attenuated progeny. Obtaining detailed knowledge of the changes which are needed for attenuation will be important for advancing our understanding of MD biology and should facilitate the development of more potent vaccines. We have determined the complete nucleotide sequence of a bacterial artificial chromosome (BAC) construct representing the 80th passage of a very virulent plus (vv+) MD virus strain termed 584A. Pathotyping studies have indicated that this strain (584Ap80) is indeed attenuated. Bioinformatic analysis of the sequencing data has identified numerous gross genetic changes clustering in the inverted repeat regions of the genome, as well as subtle changes (single nucleotide polymorphisms or SNPs) scattered throughout the genome. Relative to the parental strain (584Ap9), insertional mutations were identified in the MD-specific genes encoding RLORF1, RLORF3, RLORF6, 23 kDa, RLORF7 (Meq), vIL8, vLip, RSORF1, and five uncharacterized novel genes. Deletions were found in four locations within the 584Ap80 genome. A large deletion (297nt) was found in the diploid genes 85.6/98.6 and a 321 nt deletion within the intergenic region between the U(L)3 and U(L)3.5 genes is predicted to create a fusion polypeptide. A single nucleotide deletion was identified within the origin of replication. Both insertions and deletions were found in the dipoid genes MDV3.4/78.3 encoding the virulence factor RLORF4. The sequencing of the attenuated strain 584Ap80 and comparison to that of the virulent parent 584A passage 9 (584Ap9) has provided a wealth of information regarding genetic changes which have occurred during the attenuation process.

Nucleic Acids Res. 1988 Nov 25;16(22):10881-90. (PMID: 2849754)
Nucleic Acids Res. 1987 Oct 26;15(20):8125-48. (PMID: 3313277)
Vet J. 2005 Sep;170(2):175-83. (PMID: 16129338)
Avian Dis. 2004 Sep;48(3):471-87. (PMID: 15529969)
Brief Bioinform. 2004 Jun;5(2):150-63. (PMID: 15260895)
Nucleic Acids Res. 2001 Jul 15;29(14):2994-3005. (PMID: 11452024)
Avian Dis. 2002 Oct-Dec;46(4):925-37. (PMID: 12495054)
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402. (PMID: 9254694)
Arch Virol. 2006 Mar;151(3):537-49. (PMID: 16155725)
J Virol. 2000 Sep;74(17):7980-8. (PMID: 10933706)
J Virol. 2000 Dec;74(23):11088-98. (PMID: 11070004)
Virus Genes. 2007 Aug;35(1):41-53. (PMID: 16964553)
Cytogenet Genome Res. 2003;102(1-4):304-8. (PMID: 14970721)
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6091-6. (PMID: 10823954)
J Virol. 2005 Sep;79(18):11647-59. (PMID: 16140742)
Avian Dis. 1972 Apr;16(1):108-25. (PMID: 4337307)
Curr Top Microbiol Immunol. 2001;255:245-60. (PMID: 11217425)
Virology. 1993 Aug;195(2):638-48. (PMID: 8393240)
J Virol. 1998 Jan;72(1):48-56. (PMID: 9420199)
Avian Pathol. 2005 Apr;34(2):75-90. (PMID: 16191686)
J Virol. 1997 Nov;71(11):8886-92. (PMID: 9343253)
J Virol. 1998 Mar;72(3):2548-53. (PMID: 9499123)
J Virol. 2007 Nov;81(22):12348-59. (PMID: 17855520)
Virus Genes. 1988 Oct;2(1):49-68. (PMID: 2852415)
J Virol. 2005 Oct;79(19):12487-94. (PMID: 16160176)
J Virol. 1996 Jun;70(6):3517-27. (PMID: 8648685)
J Virol. 1992 Dec;66(12):7389-96. (PMID: 1279201)
Virus Genes. 2003 May;26(3):255-69. (PMID: 12876454)
Virus Genes. 2007 Dec;35(3):753-66. (PMID: 17721813)
Nature. 2005 Sep 15;437(7057):376-80. (PMID: 16056220)
Res Vet Sci. 2000 Aug;69(1):17-23. (PMID: 10924389)
J Virol. 1985 Jun;54(3):690-6. (PMID: 2987523)
Virology. 1996 Jul 15;221(2):368-74. (PMID: 8661449)
J Virol. 2001 Jun;75(11):5159-73. (PMID: 11333897)
Acta Virol. 1999 Apr-Jun;43(2-3):106-12. (PMID: 10696429)
Virology. 1995 Jan 10;206(1):324-38. (PMID: 7831788)
J Gen Virol. 2007 Apr;88(Pt 4):1080-1096. (PMID: 17374751)
Avian Dis. 1997 Jan-Mar;41(1):149-63. (PMID: 9087332)
J Mol Biol. 1990 Oct 5;215(3):403-10. (PMID: 2231712)
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7. (PMID: 15034147)
Nucleic Acids Res. 2005 Jan 20;33(2):511-8. (PMID: 15661851)
Arch Virol. 2007;152(9):1665-78. (PMID: 17557133)
J Virol. 2004 Jan;78(1):464-72. (PMID: 14671126)
Virology. 1995 Nov 10;213(2):590-9. (PMID: 7491783)
J Gen Virol. 2002 Oct;83(Pt 10):2367-2376. (PMID: 12237417)

GENBANK EU627065

0 (Codon, Initiator)
0 (DNA, Viral)
0 (Marek Disease Vaccines)
0 (Vaccines, Attenuated)
0 (Viral Proteins)

Date Created: 20080603 Date Completed: 20080904 Latest Revision: 20211020

20231215

10.1007/s11262-008-0242-0

18516669